Key statistics
On Friday, IMCD NV (IMCD:AEX) closed at 140.15, 10.66% above the 52 week low of 126.65 set on Jul 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 138.20 |
---|---|
High | 140.40 |
Low | 138.20 |
Bid | 137.65 |
Offer | 141.80 |
Previous close | 137.35 |
Average volume | 101.92k |
---|---|
Shares outstanding | 59.11m |
Free float | 58.11m |
P/E (TTM) | 28.41 |
Market cap | 8.28bn EUR |
EPS (TTM) | 4.93 EUR |
Annual div (ADY) | 2.24 EUR |
---|---|
Annual div yield (ADY) | 1.60% |
Div ex-date | May 16 2024 |
Div pay-date | May 21 2024 |
Data delayed at least 15 minutes, as of Nov 22 2024 16:37 GMT.
More ▼
- IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares
- IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY
- IMCD reports EBITA of EUR 403 million in the first nine months of 2024
- IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America
- IMCD successfully issues a EUR 500 million rated bond
- IMCD reports EBITA of EUR 270 million in the first half of 2024
- IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
More ▼